162 related articles for article (PubMed ID: 3894513)
1. Depressor effects of captopril in DOCA-salt hypertensive rats: role of vasopressin.
Igarashi Y; Suzuki H; Itaya Y; Kondo K; Saruta T
J Hypertens; 1985 Apr; 3(2):149-53. PubMed ID: 3894513
[TBL] [Abstract][Full Text] [Related]
2. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
Chen K; Zhang X; Dunham EW; Zimmerman BG
Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
[TBL] [Abstract][Full Text] [Related]
3. Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin.
Miyamori I; Brown MJ; Dollery CT
Clin Exp Hypertens (1978); 1980; 2(6):935-45. PubMed ID: 7004806
[TBL] [Abstract][Full Text] [Related]
4. Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats.
Itaya Y; Suzuki H; Matsukawa S; Kondo K; Saruta T
Am J Physiol; 1986 Aug; 251(2 Pt 2):H261-8. PubMed ID: 3526927
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
6. Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats.
Morton JJ; Garcia del Rio C; Hughes MJ
Clin Sci (Lond); 1982 Feb; 62(2):143-9. PubMed ID: 7053914
[TBL] [Abstract][Full Text] [Related]
7. Effect of intracerebroventricular captopril on vasopressin and blood pressure in spontaneously hypertensive rats.
Crofton JT; Rockhold RW; Share L; Wang BC; Horovitz ZP; Manning M; Sawyer WH
Hypertension; 1981; 3(6 Pt 2):II-71-4. PubMed ID: 7028623
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
[TBL] [Abstract][Full Text] [Related]
9. [Effects of single and repeated oral administration of MK-421 and captopril on blood pressures in normotensive and experimental hypertensive rats].
Ohmura I; Maki E; Naruse T; Chen CS; Ikeda N; Asami T
Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):293-302. PubMed ID: 3002925
[TBL] [Abstract][Full Text] [Related]
10. Effect of trichlormethiazide and captopril on nitric oxide synthase activity in the kidney of deoxycorticosterone acetate-salt hypertensive rats.
Takanohashi A; Tojo A; Kobayashi N; Yagi S; Matsuoka H
Jpn Heart J; 1996 Mar; 37(2):251-9. PubMed ID: 8676552
[TBL] [Abstract][Full Text] [Related]
11. Chlorthalidone reduces vascular hyperresponsiveness in DOCA-salt hypertensive rats.
Cabral AM; Musso MN; Bissoli NS; Carvalhinho FB; Vasquez EC
Clin Exp Hypertens A; 1992; 14(4):667-83. PubMed ID: 1628412
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular responses of conscious DOCA-salt hypertensive rats to acute intracerebroventricular and intravenous administration of captopril.
Pochiero M; Nicoletta P; Losi E; Bianchi A; Caputi AP
Pharmacol Res Commun; 1983 Feb; 15(2):173-82. PubMed ID: 6342005
[TBL] [Abstract][Full Text] [Related]
13. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
Wang H; McNeill JR
Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
[TBL] [Abstract][Full Text] [Related]
14. Hypotensive effect of captopril on deoxycorticosterone acetate-salt-induced hypertensive rat is associated with gut microbiota alteration.
Wu H; Lam TYC; Shum TF; Tsai TY; Chiou J
Hypertens Res; 2022 Feb; 45(2):270-282. PubMed ID: 34857899
[TBL] [Abstract][Full Text] [Related]
15. Outcomes to middle cerebral artery occlusion in hypertensive and normotensive rats.
Coyle P
Hypertension; 1984; 6(2 Pt 2):I69-74. PubMed ID: 6373599
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin-central nervous system interactions in the development of DOCA hypertension.
Berecek KH; Barron KW; Webb RL; Brody MJ
Hypertension; 1982; 4(3 Pt 2):131-7. PubMed ID: 7068203
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic angiotensin-converting enzyme blockade on pressor responses to exogenous angiotensin II, noradrenaline and vasopressin in deoxycorticosterone acetate salt (DOCA)-induced hypertensive rats.
Gan EK; Abas A; Latiff A
Jpn J Pharmacol; 1984 Oct; 36(2):147-51. PubMed ID: 6096611
[TBL] [Abstract][Full Text] [Related]
18. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin and the hypotensive action of captopril in DOCA salt hypertensive rats [proceedings].
Dollery CT; Miyamori I
Br J Pharmacol; 1980 Jan; 68(1):117P-118P. PubMed ID: 6986936
[No Abstract] [Full Text] [Related]
20. Are sodium-dependent V1 receptors and sympathetic nerve activations involved in regulation of blood pressure in borderline-hypertensive Hiroshima rats?
Teranishi Y; Kumazaki T; Miho N; Sugino H; Tsuru H
Hypertens Res; 2002 Sep; 25(5):763-71. PubMed ID: 12452331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
